| 0 (0%) | 09-27 09:27 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 17.62 | 1-year : | 18.25 |
| Resists | First : | 15.08 | Second : | 15.63 |
| Pivot price | 14.75 |
|||
| Supports | First : | 14.21 | Second : | 11.82 |
| MAs | MA(5) : | 14.61 |
MA(20) : | 14.75 |
| MA(100) : | 12.42 |
MA(250) : | 15.1 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 19.7 |
D(3) : | 30.6 |
| RSI | RSI(14): 47.7 |
|||
| 52-week | High : | 20.72 | Low : | 10.23 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ OFIX ] has closed above bottom band by 10.9%. Bollinger Bands are 36.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 14.45 - 14.54 | 14.54 - 14.6 |
| Low: | 14.02 - 14.14 | 14.14 - 14.22 |
| Close: | 14.14 - 14.31 | 14.31 - 14.42 |
Sat, 27 Sep 2025
Gradient Capital Advisors LLC Purchases New Stake in Orthofix Medical Inc. $OFIX - MarketBeat
Thu, 25 Sep 2025
Counterpoint Mutual Funds LLC Takes Position in Orthofix Medical Inc. $OFIX - MarketBeat
Tue, 23 Sep 2025
New Analyst Forecast: $OFIX Given $17.0 Price Target - Quiver Quantitative
Tue, 23 Sep 2025
Barrington Research Reaffirms Outperform Rating for Orthofix Medical (NASDAQ:OFIX) - MarketBeat
Mon, 15 Sep 2025
Do You Believe in the Growth Potential of Orthofix Medical (OFIX)? - Yahoo Finance
Tue, 09 Sep 2025
Orthofix Medical: Spending, Not Producing Additional Income (NASDAQ:OFIX) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 39 (M) |
| Shares Float | 39 (M) |
| Held by Insiders | 2.7 (%) |
| Held by Institutions | 91.9 (%) |
| Shares Short | 1,820 (K) |
| Shares Short P.Month | 2,420 (K) |
| EPS | -3.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 11.6 |
| Profit Margin | -15.3 % |
| Operating Margin | -8.3 % |
| Return on Assets (ttm) | -6 % |
| Return on Equity (ttm) | -24.7 % |
| Qtrly Rev. Growth | 2.2 % |
| Gross Profit (p.s.) | 14.11 |
| Sales Per Share | 20.48 |
| EBITDA (p.s.) | 0.4 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 29 (M) |
| Levered Free Cash Flow | 56 (M) |
| PE Ratio | -4.51 |
| PEG Ratio | 0 |
| Price to Book value | 1.23 |
| Price to Sales | 0.69 |
| Price to Cash Flow | 19.69 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|